Heron Therapeutics (HRTX) Earnings Date, Estimates & Call Transcripts $1.63 +0.06 (+3.82%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Heron Therapeutics Latest Earnings SummaryUpcoming Q4 Earnings DateMar. 10After Market ClosesEstimatedActual EPS (Nov. 12) -$0.03 Consensus EPS (Nov. 12) -$0.03 Heron Therapeutics released Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.03, which hit the consensus estimate of -$0.03. Quarterly revenue was reported to be $32.81 million, below analyst estimates of $36.40 million. With a trailing EPS of -$0.18, Heron Therapeutics' earnings are expected to grow next year, from ($0.13) to ($0.05) per share. Conference CallConference Call TranscriptEarnings Press ReleaseEarnings Slide DeckPowered by HRTX Upcoming EarningsHeron Therapeutics' next earnings date is estimated for Monday, March 10, 2025, based off prior year's reporting schedules. Get Heron Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Heron Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataHRTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.HRTX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Heron Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.13) EPSNext Year EPS Consensus Estimate: ($0.05) EPS Heron Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 3/10/2025(Estimated)-------11/12/2024Q3 2024-$0.03-$0.03--$0.03$36.40M$32.81M8/6/2024Q2 2024-$0.04-$0.06 -$0.02-$0.06$35.35M$36.02M5/7/2024Q1 2024-$0.08-$0.02+$0.06-$0.02$32.50M$34.67M3/12/2024Q4 2023-$0.15-$0.07+$0.08-$0.07$30.98M$34.23M11/14/2023Q3 2023-$0.31-$0.17+$0.14-$0.17$31.63M$31.43M8/14/2023Q2 2023-$0.23-$0.35 -$0.12-$0.35$31.75M$31.76M5/11/2023Q1 2023-$0.17-$0.27 -$0.10-$0.27$28.30M$29.62M3/23/2023Q4 2022-$0.25-$0.17+$0.08-$0.17$27.24M$30.00M Heron Therapeutics Earnings - Frequently Asked Questions When is Heron Therapeutics's earnings date? Heron Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 10th, 2025 based off last year's report dates. Learn more on HRTX's earnings history. What guidance has Heron Therapeutics issued on next quarter's earnings? Heron Therapeutics updated its FY 2024 earnings guidance on Tuesday, November, 12th. The company issued revenue guidance of $140.0 million-$146.0 million, compared to the consensus revenue estimate of $148.4 million. Did Heron Therapeutics beat their earnings estimates last quarter? In the previous quarter, Heron Therapeutics (NASDAQ:HRTX) reported ($0.03) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.03). Learn more on analysts' earnings estimate vs. HRTX's actual earnings. How can I listen to Heron Therapeutics's earnings conference call? The conference call for Heron Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Heron Therapeutics's conference call transcript? The conference call transcript for Heron Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Heron Therapeutics generate each year? Heron Therapeutics (NASDAQ:HRTX) has a recorded annual revenue of $127.04 million. How much profit does Heron Therapeutics generate each year? Heron Therapeutics (NASDAQ:HRTX) has a recorded net income of -$110.56 million. HRTX has generated -$0.18 earnings per share over the last four quarters. What is Heron Therapeutics's EPS forecast for next year? Heron Therapeutics's earnings are expected to grow from ($0.13) per share to ($0.05) per share in the next year. More Earnings Resources from MarketBeat Related Companies Oculis Earnings Results Nuvation Bio Earnings Results Anavex Life Sciences Earnings Results CureVac Earnings Results AbCellera Biologics Earnings Results ArriVent BioPharma Earnings Results Cogent Biosciences Earnings Results Phibro Animal Health Earnings Results Relay Therapeutics Earnings Results Avid Bioservices Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? This page (NASDAQ:HRTX) was last updated on 1/19/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heron Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heron Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
